A randomized open-label trial of deprescribing proton pump inhibitors to reduce the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation

Administered By

Awarded By

Contributors

Start/End

  • August 1, 2022 - August 1, 2023